PharmiWeb1d
Global Progressive Fibrosing Interstitial Lung Disease Market Projected to Reach USD 8654.1 Million by 2033 at a 6.2% of CAGR
The Progressive Fibrosing Interstitial Lung Disease (PF-ILD) market is currently valued at USD 4,742.2 Million in 2023 and is ...
emjreviews.com2d
Inhalation Innovation: Phase IIb Study Design of Inhaled Pirfenidone in the Treatment of Progressive Pulmonary Fibrosis
Progressive pulmonary fibrosis (PPF) is an increasingly recognised condition, defined in 2022 to address the progression of ...
emjreviews.com2d
Heterogeneity of Inflammatory Processes and Pathways Driving Chronic Obstructive Pulmonary Disease Pathology
A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...
precisionmedicineonline2d
Study Identifies Predictive Biomarker of Response to Anti-Fibrotic Therapy in Early Breast Cancer
NEW YORK – Researchers have identified a gene signature that can predict whether early-stage breast cancer patients will ...